Teva recalls US-made drugs following contamination fears - The Boston Globe
Lured by $40 million tax break, Teva moving U.S. headquarters from Pa. to North Jersey - WHYY
Teva Pharmaceutical reports Q1 2018 | AlphaStreet
Teva Pharmaceuticals in peer group American glamour stocks | Valuespectrum.com
Teva Pharmaceuticals soars after Warren Buffett's Berkshire Hathaway discloses a stake (TEVA) | Markets Insider
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug Ajovy | BioSpace
Teva down as it reports lower sales and profit for 2018
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Teva restructuring hits American HQ, claiming 200-plus Pennsylvania jobs | Fierce Pharma
Teva | Partnership | Direct Relief
Teva Pharmaceuticals - Wikipedia
FDA approves Teva's generic EpiPen after yearslong delay
Teva, Murphy Formalize North America Headquarters Move with Ceremony in Israel - New Jersey Business Magazine
Teva Pharmaceuticals considering 345,000 sq. ft. in Parsippany | Parsippany Focus
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
Teva Pharmaceuticals - Wikipedia
Teva's Turnaround: Is It Ever Or Never?
Teva Pharmaceuticals moving HQ to New Jersey – thereporteronline
Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics | BioSpace
Pharma giant Teva promises to create over 800 jobs in N.J. Are they worth $40M? - nj.com
BCBS Vermont suing Teva Pharmaceuticals over MS drug marketing | Healthcare Finance News
Teva Reports Massive $11.6 Billion Loss, Predicts Weak 2018 - Business - Haaretz.com
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Teva Pharmaceutical Industries (NASDAQ:TEVA) Share Price | RNS News, Quotes, & Charts | TEVA
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
